• Clinical Technology
  • Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Nephrology
  • Neurology
  • Pulmonology

google plus one (home page)

Article

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
Cervical Cancer Screening in Primary Care: A Q&A with Family Physician Ada Stewart, MD

Cervical Cancer Screening in Primary Care: A Q&A with Family Physician Ada Stewart, MD

Ada Stewart, MD;Sydney Jennings
September 19th 2025
Article

Explore essential insights on cervical cancer screening, patient engagement, and innovative self-collection methods this Gynecologic Cancer Awareness Month.

Weekly Dose Podcast: Cervical Cancer Disparities, HPV Awareness Gaps, Depression Risk After Diagnosis, PharmFIT Preferences, and Semaglutide for MASH

Weekly Dose Podcast: Cervical Cancer Disparities, HPV Awareness Gaps, Depression Risk After Diagnosis, PharmFIT Preferences, and Semaglutide for MASH

Sydney Jennings
September 17th 2025
Podcast

This week’s podcast episode covers cervical cancer disparities, HPV awareness, depression risk, pharmacy CRC screening, and semaglutide approval for MASH.

FDA Approves Ruxolitinib for Pediatric Patients Aged 2-11 Years as First Topical JAK Inhibitor for the Age Group / image credit ©Waldenmarus/stock.adobe.com

FDA Approves Ruxolitinib for Pediatric Patients Aged 2-11 Years as First Topical JAK Inhibitor for the Age Group

Grace Halsey
September 19th 2025
Article

Incyte announced the agency's decision, which was based on findings of significant reduction in AD signs and symptoms during the TRuE-AD3 clinical trial.

Weekly Dose Podcast: Psoriasis Drug Success, Intranasal Insulin Insights, and New Data on Vaccines and GLP-1 Use

Weekly Dose Podcast: Psoriasis Drug Success, Intranasal Insulin Insights, and New Data on Vaccines and GLP-1 Use

Sydney Jennings
September 5th 2025
Podcast

This week’s podcast covers psoriasis trial results, intranasal insulin, COVID-19 booster safety, GLP-1 use in diabetes, and RSV vaccine uptake.

Vaginal Estradiol Shows No Added Risk of Repeat Stroke in Women: Daily Dose / image credit: ©New Africa/AdobeStock

Vaginal Estradiol Shows No Added Risk of Repeat Stroke in Women: Daily Dose

Sydney Jennings
September 19th 2025
Article

Your daily dose of the clinical news you may have missed.

OX40 Inhibitor Rocatinlimab Shows Significant Response in Combination with Topical Therapy for AD / image courtesy of Oregon Health and Sciences university - Eric Simpson, MD

OX40 Inhibitor Rocatinlimab Shows Significant Response in Combination with Topical Therapy for AD

Grace Halsey
September 19th 2025
Article

EADV 2025: Phase 3 ROCKET-SHUTTLE results showed the T-cell rebalancing therapy significantly improved AD signs and symptoms in treatment-experience adults.

© 2025 MJH Life Sciences

All rights reserved.